Rocket Pharmaceuticals Inc Working Capital to Net Assets Ratio
Rocket Pharmaceuticals Inc working capital to net assets ratio. Rocket Pharmaceuticals Inc (RCKT) has a Working Capital to Net Assets ratio of 70.0% as of June 2026. Working capital of $258.23 Million (current assets of $289.55 Million minus current liabilities of $31.32 Million) is measured against net assets of $368.83 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check RCKT tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Rocket Pharmaceuticals Inc (2012–2025)
Working capital to net assets ratio of Rocket Pharmaceuticals Inc from 2012 to 2025. This chart shows how Rocket Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 70.0%, reflecting working capital of $258.23 Million against net assets of $368.83 Million USD. See Rocket Pharmaceuticals Inc (RCKT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Rocket Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2012–2025)
Rocket Pharmaceuticals Inc working capital to net assets ratio by year from 2012 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Rocket Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Rocket Pharmaceuticals Inc balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 58.6% | $162.53 Million | $277.22 Million | $192.73 Million | $30.21 Million | ▼ -14.2 pp |
| 2024 | 72.9% | $337.50 Million | $463.23 Million | $378.18 Million | $40.68 Million | ▲ +5.9 pp |
| 2023 | 66.9% | $329.72 Million | $492.57 Million | $378.22 Million | $48.51 Million | ▲ +0.6 pp |
| 2022 | 66.3% | $324.89 Million | $489.69 Million | $364.06 Million | $39.17 Million | ▼ -15.0 pp |
| 2021 | 81.3% | $369.89 Million | $454.72 Million | $392.06 Million | $22.17 Million | ▼ -9.0 pp |
| 2020 | 90.3% | $454.73 Million | $503.52 Million | $487.35 Million | $32.62 Million | ▼ -3.9 pp |
| 2019 | 94.2% | $289.44 Million | $307.30 Million | $307.75 Million | $18.31 Million | ▼ -5.6 pp |
| 2018 | 99.8% | $193.72 Million | $194.04 Million | $209.09 Million | $15.37 Million | ▼ -103.2 pp |
| 2017 | 203.0% | $96.98 Million | $47.76 Million | $101.05 Million | $4.07 Million | ▲ +37.5 pp |
| 2016 | 165.6% | $121.14 Million | $73.17 Million | $128.35 Million | $7.21 Million | ▲ +66.1 pp |
| 2015 | 99.5% | $108.22 Million | $108.81 Million | $112.37 Million | $4.14 Million | ▲ +99.3 pp |
| 2014 | 0.2% | $-85.00K | $-51.56 Million | $3.62 Million | $3.70 Million | ▲ +25.0 pp |
| 2013 | -24.8% | $9.64 Million | $-38.90 Million | $12.86 Million | $3.22 Million | ▼ -32.4 pp |
| 2012 | 7.6% | $-2.35 Million | $-30.93 Million | $1.42 Million | $3.77 Million | — |